CD8A and neoplasm: CD73 on CD8 T cells seems to significantly contribute to the anti-tumor immunity response, since adoptively transferred CD73-deficient ovalbumin-specific OT-I T cells were more potent in killing OVA-expressing B16 melanoma tumors compared to WT OT-I T cells (47).